Royal Philips has announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the new eL18-4 transducer with full solution for “small parts” assessment, which is an ultrasound exam to detect abnormalities in the small organs that are close to the skin.
The Philips Ultimate Small Parts Solution features four key innovations that work together to help improve patient care: the eL18-4 PureWave linear array transducer, Philips MicroFlow Imaging, Philips Elastography and Philips Precision Biopsy. The new eL18-4 transducer can also be used to assess musculoskeletal injuries.
The new Philips eL18-4 PureWave linear array transducer allows fine-elevation focusing that delivers extraordinary imaging and extended depth of field performance to help clinicians evaluate small organs, including the thyroid gland, and diagnose a variety of conditions.
The new Philips eL18-4 PureWave linear array transducer allows fine-elevation focusing that delivers extraordinary imaging and extended depth of field performance to help clinicians evaluate small organs, including the thyroid gland, and diagnose a variety of conditions.